<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="49590">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02460640</url>
  </required_header>
  <id_info>
    <org_study_id>Tap Block</org_study_id>
    <nct_id>NCT02460640</nct_id>
  </id_info>
  <brief_title>Treatment of Acute and Chronic Pain in the Minimally Invasive Partial Nephrectomy: Tap Block vs Intravenous Pca</brief_title>
  <official_title>Treatment of Acute and Chronic Pain in the Minimally Invasive Partial Nephrectomy: Transversus Abdominis Plane Block vs Intravenous Patient Controlled Analgesia. Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Elena Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regina Elena Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center study in order to assess whether the tap block can make extremely beneficial
      in terms of reducing the acute and chronic pain as well as for use of opioids and side
      effects related to it in patients undergoing surgery to minimally invasive partial
      nephrectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute pain after surgery measured with visual analogue scale</measure>
    <time_frame>every day after surgery until patient's discharge up to 10 days</time_frame>
    <description>acute pain will be measured with visual analogue scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chronic pain after surgery measured with questionnaire called PainDetect</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>chronic pain will be ; tactile and pain threshold with hair's von frey</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Pain</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Tap Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the intervention will be tap block after induction of anesthesia with ropivacaine 0,5% 15ml and continuous patient-controlled analgesia with morphine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Tap Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patients who not receive tap block but they will be as intervention intravenous Patient controlled analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tap block</intervention_name>
    <description>intravenous patient-controlled analgesia with morphine and tap block with subcostal and posterior approach with ropivacaine 0,5% 15ml+15ml</description>
    <arm_group_label>Tap Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>intravenous Patient controlled analgesia</intervention_name>
    <description>intravenous patient-controlled analgesia with morphine</description>
    <arm_group_label>Tap Block</arm_group_label>
    <arm_group_label>No Tap Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>Tap Block</arm_group_label>
    <arm_group_label>No Tap Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Tap Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asa score I,II,II

          -  informed consent signed

        Exclusion Criteria:

          -  previous abdominal surgery

          -  diseases of the central or peripheral nervous system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ester Forastiere, M.D.</last_name>
    <phone>00390652662995</phone>
    <email>forastiere@ifo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Regina Elena CI</name>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ester Forastiere, M.D.</last_name>
      <email>forastiere@ifo.it</email>
    </contact>
    <investigator>
      <last_name>Ester Forastiere, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Covotta, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 6, 2016</lastchanged_date>
  <firstreceived_date>May 19, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regina Elena Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ester Forastiere</investigator_full_name>
    <investigator_title>Head of Anestesiology and Critical Care Department</investigator_title>
  </responsible_party>
  <keyword>Minimally invasive surgery</keyword>
  <keyword>Partial nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
